XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.2

Revenues (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2022 and 2021:

			Three months ended June 30,												Six months ended June 30,
			2022						2021						2022						2021
Products:
Kristalose			$	3,570,272					$	5,275,065					$	7,515,368					$	8,269,443
Sancuso			3,398,548						—						6,795,758						—
Vibativ			1,596,821						1,844,936						4,098,255						6,897,179
Caldolor			1,193,916						938,328						2,153,546						2,477,824
Vaprisol			(134,621)						399,952						(251,623)						1,534,216
Acetadote			126,789						152,781						237,884						269,972
Omeclamox-Pak			(26,412)						(24,109)						(3,676)						(474,371)
RediTrex			93,676						7,382						152,904						(24,870)
Other revenue			480,163						461,148						775,781						643,249
Total net revenues			$	10,299,152					$	9,055,483					$	21,474,197					$	19,592,642

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration